Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Dr. Juan E. Mezzich y Dr. Miguel R. Jorge: ¡Bienvenidos a Psiquiatría y Salud Integral!
1
x
$
0.00
Drug Induced Mania in a Boy with High Functioning Autism
1
x
$
30.00
Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
1
x
$
30.00
Maria Dolores Escarabajal, PhD: DDTC, a Metabolite of Disulfiram, Reduces the Stimulating Effect on Ethanol’s Locomotor Activity in Mice
1
x
$
30.00
Nienke Dekker, MD: Cessation of Cannabis Use by Patients with Recent-Onset Schizophrenia and Related Disorders
1
x
$
30.00
Branimir Margetic: A Case of Stuttering During Treatment with Levomepromazine
1
x
$
30.00
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder
1
x
$
30.00
Desvenlafaxine and Venlafaxine Exert Minimal In Vitro Inhibition of Human Cytochrome P450 and P-Glycoprotein Activities
1
x
$
30.00
A Discussion on the Methodologies Used to Evaluate Antidepressants
1
x
$
15.00
Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
1
x
$
30.00
Recent-Onset Schizophrenia and Adolescent Cannabis Use: MRI Evidence for Structural Hyperconnectivity?
1
x
$
30.00
Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis
1
x
$
30.00
A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide
1
x
$
30.00
View Cart
Checkout
Home
Store
You cannot add another "Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients" to your cart.
View cart
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Establishing a ‘Gateway’ for Patients with Anxiety
$
0.00
Add to cart
Details
WHEN BIGGER IS BETTER: Necessity as the Mother of Medical Invention
$
0.00
Add to cart
Details
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
$
0.00
Add to cart
Details
Neuropsychiatric Update: Neuroimaging Schizophrenia
$
0.00
Add to cart
Details
Genetics of Schizophrenia: Recent Advances
$
0.00
Add to cart
Details
Gender and Schizophrenia
$
0.00
Add to cart
Details
Efficacy of Combined Pharmacological and Cognitive- Behavioral Treatments For Anxiety Disorders
$
0.00
Add to cart
Details
Psychiatric Bulletin: Late-Breaking Clinical News
$
0.00
Add to cart
Details
The MentalFitness Interview: David Shaffer, FRCP, FRCPsych, on the Rise and Fall of the Teen Suicide Rate
$
0.00
Add to cart
Details
Cause & Effect: Dealing with the Loss of a Spouse
$
0.00
Add to cart
Details
Anxiety Disorders: Vast Progress but a Long Journey Ahead
$
0.00
Add to cart
Details
Economic Impacts of Anxiety Disorders
$
0.00
Add to cart
Details
Panic Disorder During Pregnancy
$
0.00
Add to cart
Details
Recognition and Treatment of Anxiety Disorders in Primary Care
$
0.00
Add to cart
Details
Anxiety and Other Emotional Factors in Noncardiac Chest Pain
$
0.00
Add to cart
Details
Does Isotretinoin Cause Depression and Suicide? By J. Douglas Bremner, MD
$
0.00
Add to cart
Details
Nota del Director Editorial: En vivo desde Nueva York, les presentamos Psiquiatría y Salud Integral
$
0.00
Add to cart
Details
Dr. Juan E. Mezzich y Dr. Miguel R. Jorge: ¡Bienvenidos a Psiquiatría y Salud Integral!
$
0.00
Add to cart
Details
Psiquiatría y Salud Integral: El consejo editorial de PSI incluye los siguientes psiquiatras y médicos:
$
0.00
Add to cart
Details
Utilización del nombre de los fármacos
$
0.00
Add to cart
Details
1
2
…
44
Next
Page load link
Go to Top
